CurrentCentenePolicy CP.MP.82

NICU Apnea Bradycardia Discharge Guidelines

Guideline/policy defining clinical criteria for readiness for discharge from inpatient neonatal care for infants with apnea, bradycardia, desaturation events or receiving caffeine citrate, and guidance for continued stay approvals and home monitoring.

Policy Summary

PayerCentene

PolicyNICU Apnea Bradycardia Discharge Guidelines

Policy CodePolicy CP.MP.82

Change TypeRevisions and clarifications to discharge criteria (e.g., 5-7 day observation, thresholds updated)

Effective Date

Next Review Date

Key ActionDocument that the infant had no clinically significant cardiorespiratory events for five to seven days prior to discharge or met allowed alternative conditions, and record required evaluations and caregiver training for home monitoring.

SourceLink

POLICY UPDATE CHANGES

Changed requirement for no clinically significant events before discharge from '5' to '5-7' days in I.A.1 and I.B.

Updated oxygen saturation criterion from <85% to ≤85% and clarified wording in several criteria (I.A.1.c, I.A.2.a, I.A.2.b, I.A.3.d, I.A.3.e).

Updated isolated bradycardia threshold from <70 to <80 beats per minute and changed wording to 'isolated bradycardia'.

Clarified that apnea <20s with frequent desaturations ≤85% qualifies as clinically significant unless transient and resolved without supplemental oxygen.

Expanded guidance that caffeine may remain therapeutic up to ten days after discontinuation.

Title changed from 'Guidelines' to 'Policy/Criteria' and added Centene affiliation language.

5-7 daysRequired event-free observation interval

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Apnea duration threshold

≤85%Desaturation threshold

<80 bpmBradycardia threshold

Coverage Summary

This policy (CP.MP.82) provides clinical criteria for readiness for discharge from inpatient neonatal care for infants with apnea, bradycardia, desaturation events, or who have received caffeine citrate. Status: CURRENT. Last review: 2026-06-25.

Policy thresholds (from brief.thresholds)

Observation spell-free interval5-7 days

Apnea duration threshold>= 20 seconds

Bradycardia heart rate threshold< 80 beats per minute

Oxygen desaturation threshold≤ 85%

Caffeine-free interval before discharge>= 7 days

Discharge Readiness Criteria (Medical Necessity)

Discharge from inpatient care for significant cardiorespiratory events

Infants may be considered ready for discharge when meeting ALL of the following, as applicable:

Infant demonstrates maturity of respiratory control and ONE of the following
- No clinically significant cardiorespiratory events for five to seven days prior to discharge
  - No apnea ≥ 20 seconds
  - No apnea < 20 seconds with bradycardia of < 80 beats per minute< 80 beats per minute
  - No apnea < 20 seconds with valid, prolonged or frequent oxygen desaturations ≤ 85% (excludes transient oxygen desaturation ≤ 85% unless requiring supplemental oxygen to resolve)≤ 85%

Definitions and Evidence

Apnea of prematurity is common in premature infants and is often closely associated with bradycardia; it frequently prolongs NICU length of stay and contributes to parental anxiety. The Committee on Fetus and Newborn defines apnea of prematurity as a cessation of breathing lasting at least 20 seconds or a shorter pause accompanied by bradycardia, cyanosis, or pallor in infants <37 weeks' gestational age. Most cases resolve by 37 weeks post-conceptional age, though very preterm infants may persist longer.

Caffeine citrate is a recommended pharmacologic treatment for apnea of prematurity. It has a relatively long half-life in preterm infants (mean ~100 hours), supports once-daily dosing, and because of its long half-life may remain therapeutic for up to ten days after discontinuation. Maintenance dosing typically begins 24 hours after a loading dose at 5–10 mg/kg daily; routine drug levels are not generally required unless toxicity is suspected.

Home cardiorespiratory monitoring is indicated for infants with ongoing conditions that increase the risk for apnea, airway obstruction, or hypoxemia — examples include persistent apnea of prematurity, chronic lung disease (especially when supplemental oxygen or positive airway pressure is needed), congenital neuromuscular disorders, tracheostomy or other airway abnormalities. Discharge planning should consider these indications along with caregiver training and home situation assessment.

Clinically significant cardiorespiratory event: Apnea ≥ 20 seconds, OR apnea < 20 seconds with bradycardia < 80 bpm, OR apnea < 20 seconds with valid, prolonged, or frequent desaturations ≤ 85%, OR any event requiring stimulation, artificial ventilation, or supplemental oxygen to restore normal breathing, heart rate, or oxygenation.

Isolated bradycardia: Bradycardia < 80 beats per minute that is unrelated to feedings.

Required Provider Documentation & Actions

Documentation Required

Record absence of clinically significant events

Document that the infant had no clinically significant cardiorespiratory events (apnea, bradycardia, desaturation) for five to seven days prior to discharge, or that the infant met alternative allowed conditions (e.g., reflux-related improvement or non-clinically significant spells) per the policy. This documentation should reference the specific event definitions and the 5–7 day observation interval.

Evidence of no clinically significant events for five to seven days prior to discharge (I.A.1)
Reference to I.A.1 event definitions (apnea ≥20 s; apnea <20 s with bradycardia <80 bpm; desaturations ≤85%; no events requiring stimulation/ventilation/oxygen)

Documentation Required

Document respiratory support level stability

If nasal cannula airflow is being used to manage apnea or bradycardia, document that the infant has been free of clinically significant cardiorespiratory events for five to seven days while on the same level of support planned for discharge (applies to the same level of support planned for discharge).

Five to seven days event-free while on the same nasal cannula support planned for discharge (I.B)

Policy Revision Timeline

04/21revision

Changed requirement for no clinically significant events before discharge from '5' to '5-7' days in I.A.1 and I.B.; References reviewed and updated.

05/21approval

Approval noting change in I.A.1 and I.B. to require five to seven days event-free observation prior to discharge.

06/21revision

In I.A.1 and I.B., changed requirement for no clinically significant events before discharge from '5' to '5-7' days; minor rewording and header wording changes.

Policy Summary

PayerCentene

PolicyNICU Apnea Bradycardia Discharge Guidelines

Policy CodePolicy CP.MP.82

Change TypeRevisions and clarifications to discharge criteria (e.g., 5-7 day observation, thresholds updated)

Effective Date

Next Review Date

SourceLink

On This Page

No isolated bradycardia < 80 beats per minute (unrelated to feedings)< 80 beats per minute

No events requiring stimulation, artificial ventilation (bagging or intubation), or supplemental oxygen support to restore normal breathing, heart rate, and oxygenation

Significant events continue to near-term or longer and associated with gastro-esophageal reflux

After evaluation for potential causes of apnea, the cardiorespiratory events appear to be associated with gastro-esophageal reflux
Appropriate anti-reflux measures appear to resolve or significantly reduce the severity and duration of bradycardia or apnea events (note: five days of observation may not be required in this case)

Non-clinically significant, self-limited apnea spells

Does not require stimulation to breathe again
Will be discharged to home with a cardiorespiratory monitor
There has not been a clinically significant cardiorespiratory event (defined in I.A.1) for five to seven days prior to discharge5-7 days
Parents or caregivers agree with the plan of care and have demonstrated proficiency in managing the cardiorespiratory monitor, providing stimulation, and have completed infant cardiopulmonary resuscitation (CPR) training
Home situation has been assessed and deemed adequate

If nasal cannula airflow is introduced to address apnea/bradycardia events, the infant should be free of clinically significant events for five to seven days on the same level of support planned for discharge5-7 days

applies to same level of support planned for infant's discharge

Infant has not received caffeine citrate for at least seven days prior to planned discharge>= 7 days

Infant has no additional condition(s) requiring inpatient care

Primary guidance sources: AAP 'Hospital discharge of the high-risk neonate' and multiple peer-reviewed articles and UpToDate reviews (see reference list).

See the policy reference list for specific citations and supporting literature.

Documentation Required

Document caffeine discontinuation interval

Document that the infant has not received caffeine citrate for at least seven days prior to the planned discharge, per the discharge criteria.

Caffeine citrate discontinued ≥7 days before planned discharge (I.C)

Documentation Required

Home monitoring and caregiver training

Ensure and document that parents or caregivers agree with the plan of care and have demonstrated proficiency in managing the cardiorespiratory monitor, providing stimulation, and have completed infant CPR training; document that the home situation has been assessed and deemed adequate for discharge with home monitoring.

Caregiver proficiency in cardiorespiratory monitor management
Caregiver proficiency in providing stimulation techniques
Completion of infant CPR training by caregivers
Assessment and documentation that the home situation is adequate and caregivers agree with the plan

Prior Authorization

Continued stay approval support

Use these discharge criteria to guide authorization decisions for continued inpatient stay. When requesting continued stay approval, provide documentation of the infant's cardiorespiratory events, relevant evaluations (including assessment for gastro‑esophageal reflux when applicable), and interventions implemented to manage the events.

Documentation of documented events and timing (including 5–7 day observation interval when applicable)
Evaluations performed, including reflux evaluation when events suggest reflux (I.A.2)
Interventions and responses (e.g., anti-reflux measures, respiratory support, monitoring, stimulation, therapies)

06/22revision

Annual review; expanded criteria I.A.3.c into two points, added I.A.3.d, wording changes with no impact on criteria; references reviewed and updated.

01/24revision

Added clarifying language to I.A.1.c and updated oxygen saturation percentage from <85% to ≤85%; updated wording in I.A.2.a and I.A.2.b; added caregiver agreement and home situation assessment requirements (I.A.3.d and I.A.3.e); expanded CPR information in notes.

01/25revision

Replaced 'Guidelines' title with 'Policy/Criteria'; included desaturation as clinically significant event; removed prior notation regarding percent decrease from baseline for older infants; updated isolated bradycardia threshold and wording to isolated bradycardia (<80 bpm); updated notes that caffeine may remain therapeutic up to ten days after discontinuation; added car bed and car seat assessment language.

06/25revisionLatest

Annual review with description updates and references reviewed; policy last revised/approved on 06/25 as the Date of Last Revision.